建議您使用以下瀏覽器觀看本網站，
以獲得最佳瀏覽效果。
Our team
Ken Cheng
Metagone Biotech Group Founder
- Dongguan Shun Cheng Computer Enteprise Corporation Director of Board
- Solytech Enteprise Corporation President
- Experiences in R&D and manufacturing departments of electronic components industry management for over 30 years
- Biotech investing over 10 years experience
Sean Chen Ph.D.
President/General Manager
- MS/Ph.D., Neuroscience, College of Medicine, Ohio State University, Columbus, USA
- Research Fellow, Whitehead Institute for Biomedical Research, MIT, Boston, USA
- Department Head, R&D, Genovate Biotechnology Co., Ltd. Taiwan
- Founder/Board Director/General Manager, Transwell Biotechnology Co., Ltd. Taiwan
- Experiences in Drug development for over 30 years
Da-Wen Lu, Professor, M.D., Ph.D.
Medical Director
- Director, General Ophthalmology Department, Tri-Service General Hospital
- Director, Department of Glaucoma, Tri-Service General Hospital
- Professor, Department of Ophthalmology, National Defense Medical Center
- Chairman, Taiwan association for relief of glaucoma and effective therapy
Cheng-Kuo, Cheng, Associate Professor, M.D.
Medical Director
- Director, Department of ophthalmology and Retina Center of Shin Kong Hospital
- Executive Director, Taiwan Retina Society
- Associate Professor, Department of Medicine, Fu Jen Catholic University
- Director, Department of Ophthalmology, Fu Jen Catholic University
- Adjunct Assistant Professor, Department of Medicine, National Taiwan University
Cheng-Wen Lin Ph.D.
Chief Scientific Officer
- Ph.D., Biomedical Engineering, Durham, NC, Duke University
- Postdoctoral Fellow, Durham, NC, Duke University Eye Center
- Director of Research (Executive level), Aerie Pharmaceuticals, Inc. (now Alcon)
- Chief Scientific Officer, Perfuse Therapeutics, Inc.
- Experiences in ocular drug research and development for over 15 years
- Discovered and developed two marketed products (Rhopressa® & Rocklatan®)
Akaphot Thongmee (Mark), M.D.
Chief Medical Officer
- Master., Research in Clinical Research, Imperial College London, UK
- Global Head, Medical Affairs, Grand Pacific Contract Research Organization (GPCRO)
- Medical Affairs Head (TH&VN) at Allergan Ltd.
- Country Medical Lead at Amgen (Thailand) Ltd.
- Medical advisor, Department of Oncology, Novartis International AG.
- Medical advisor/Product physician, Innovative oncology portfolio, Pfizer (Thai) Ltd.
- More than 20 years of medical advisor experience at multinational pharmaceutical companies
Simon Huang
Executive Vice President
- NYIT M.B.A.
- Barits Securities Corporation Researcher
- Solytech Enteprise Corporation Independent President
- Taipei Biotech Association Supervisor
- Professional experiences in clinical trail over 6 years
- Professional experiences (including the experiences of the securities industry and the investment company) in financial industry and capital market for over 20 years.
Amy Chen
Chief Financial Officer & Office of General Affairs, Director
- Royal Roads University M.B.A. in Executive Management
- Wayi International Digital Entertainment Co.,Ltd. Manager
- Professional experiences in financial management and fund allocation for over 25 years.
Te Chung Yang
Product Evaluation and Market Research, Director
- National Defense Medical Center Master of Pharmacy Institute
- Tri-Service General Hospital, Department of Clinical Pharmacy, Chief Pharmacist
- Tri-Service General Hospital, Department of Clinical Pharmacy, Quality Control and Clinical Trial Pharmacist
- Tri-Service General Hospital, Department of Clinical Pharmacy, Head of Neihu Outpatient Pharmacy Bureau
- Experiences in Clinical Pharmacy over 30 years
